drugset / Trial / NCT02245724
Stem Cell Therapy in Mental Retardation
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to analyze the benefit of autologous mononuclear cell therapy in mental retardation.
Timeline
- Start
- 2011-09
- Primary completion
- 2016-03
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous bone marrow mononuclear cells | Cell therapy | — | Intrathecal |
Indications
No indication recorded.